Skip to main content

Animations

MJFF Publications

6671 - 6680 of 8404 Results
Title
Year
  • Year
  • 2016
  • 2016
  • 2016
  • 2016
  • 2016
  • 2016
  • 2016
  • 2016
  • 2016
  • 2016
  • Summary Details
    OPEN
    Title: Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000161
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww307
    Citation Count: 148
  • Summary Details
    RESTRICTED
    Title: Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/aww261
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Progression of Regional Microstructural Degeneration in Parkinson’s Disease: A Multicenter Diffusion Tensor Imaging Study
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0165540
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Intake of antioxidant vitamins and risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26819
    Citation Count: 102
  • Summary Details
    RESTRICTED
    Title: c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2016.00254
    Citation Count: 38
  • Summary Details
    OPEN
    Title: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.19809
    Citation Count: 117
  • Summary Details
    OPEN
    Title: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?
    Journal Name: Hippocampus
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hipo.22671
    Citation Count: 158
  • Summary Details
    OPEN
    Title: CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson’s Disease—A Preliminary Report
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0164762
    Citation Count: 17
  • Summary Details
    OPEN
    Title: White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep35601
    Citation Count: 42
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.